GWAAIS 2022 Academic Conference Series - September 21
Food Allergy: Updates on Diagnosis and Immunotherapy. This lecture will examine the most updaed laboratory technologies and the use of immunomodulating therapies to include sublingual and oral immunotherapies.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and Greater Washington Allergy, Asthma & Immunology Society (GWAAIS). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.”
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists, fellows- in- training in allergy and immunology, primary care physicians, and allied health care providers in the field of allergy and immunology.
Learning Objectives
Upon completion of this activity, participants should be able to:
Appropriately diagnose food allergies using the most updated laboratory technologies. Actively manage and treat food allergies using immunomodulating therapies to include sublingual and oral immunotherapies.
Greater Washington Allergy, Asthma and Immunology Society
Third Academic Conference Series 2022
September 21, 2022
Bethesda Country Club, 7601 Bradley Blvd., Bethesda, Maryland 20817, (301) 365-1700
AGENDA
6:00pm-7:00pm Exhibits | Registration | Reception
7:00pm-7:15pm Welcome & Introduction
Theodore T. Kim, MD – President, GWAAIS
7:15pm-8:15pm “Food Allergy: Updates on Diagnosis and Immunotherapy”
Speaker: Dr. Robert Wood, Professor, Pediatrics Johns Hopkins University, Baltimore, Maryland
8:15pm-8:30pm Questions and Answer Session.
8:30pm Adjourn.
Target Audience: Practicing allergists, fellows- in- training in allergy and immunology, primary
care physicians, and allied health care providers in the field of allergy and immunology.
Learning Objectives: Upon completion of this activity, participants should be able to:
Appropriately diagnose food allergies using the most updated laboratory technologies. Actively
manage and treat food allergies using immunomodulating therapies to include sublingual and oral
immunotherapies.
Accreditation: This activity has been planned and implemented in accordance with the accreditation
requirements and policies of the Accreditation Council for Continuing Medical Education through the
joint providership of the American College of Allergy, Asthma and Immunology (ACAAI) and the
Greater Washington Allergy, Asthma and Immunology Society (GWAAIS). The American College of
Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation
The American College of Allergy, Asthma and Immunology (ACAAI) designates this live activity for a
maximum of
1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
In compliance with the Americans with Disabilities Act, GWAAIS requests that any participant in
need of
accommodation contact Kay Kim, email: GWAAISDMV@gmail.com
All identified conflicts of interest have been mitigated.
The individuals listed below disclose the following financial relationships:
Robert Wood, MD, Speaker
Research Support from:
• NIAID
• CDC
• FARE
• Aimmune
• ALK
• Astellas
• DBV
• Genentech
• HAL-Allergy
• Novartis
• Regeneron
• Sanofi
• Siolta Therapeutics
Theodore Kim, MD, planner
No relevant financial relationships to disclose
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma and Immunology (ACAAI) and the Greater Washington Allergy, Asthma and Immunology Society (GWAAIS). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation
The American College of Allergy, Asthma and Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In compliance with the Americans with Disabilities Act, GWAAIS requests that any participant in need of accommodation contact Kay Kim, email: GWAAISDMV@gmail.com
Available Credit
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Attendance